REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 204. REAUTHORIZATION; REPORTING REQUIREMENTS.(a) Performance Reports.—Section 738A(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–1(a)) is amended—(1) in paragraph (1)—(A) in subparagraph (A)—(i) by striking “2013” and inserting “2018”; and(ii) by striking “the Medical Device User Fee Amendments of 2012” and inserting “the Medical Device User Fee Amendments of 2017”; and(B) in subparagraph (B), by striking “the Medical Device User Fee Amendments Act of 2012” and inserting “the Medical Device User Fee Amendments of 2017”; and(2) in paragraph (2), by striking “2013 through 2017” and inserting “2018 through 2022”.(b) Reauthorization.—Section 738A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–1(b)) is amended—(1) in paragraph (1), by striking “2017” and inserting “2022”; and(2) in paragraph (5), by striking “2017” and inserting “2022”.